top of page

News

The United States Patent and Trademark Office has notified CNS that they will be issued a patent on December 27th, 2022, for several unique pharmaceuticals which we believe will be useful for treating neurodegenerative diseases.

On Wednesday, November 2nd, Dr. Smith's abstract regarding alpha-synuclein seed-amplification was presented at the NEALS convention in Clearwater, Florida.


The presentation was given by one of the authors, Dr. Robert Bowser and the poster that was presented is below.






© 2021 by Center for Neurologic Study.

bottom of page